D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial
Authors:
- Dominic SnijdersDSDominic Snijders
- Margreet SchoorlMSMargreet Schoorl
- Marianne SchoorlMSMarianne Schoorl
- Piet C BartelsPBPiet C Bartels
- Tjip S Van Der WerfTWTjip S Van Der Werf
- Wim G BoersmaWBWim G Boersma
- 1 July 2012
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 23 (5) , 436-441
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prevalence and Significance of Coagulation Abnormalities in Community-Acquired PneumoniaMolecular Medicine, 2009
- Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumoniaThorax, 2009
- Review: Novel targets in the management of pneumoniaTherapeutic Advances in Respiratory Disease, 2008
- Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired PneumoniaChest, 2004
- Coagulation in sepsisIntensive Care Medicine, 2004
- A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumoniaBlood Coagulation & Fibrinolysis, 2003
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax, 2003
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Prognosis and Outcomes of Patients With Community-Acquired PneumoniaJAMA, 1996